Clean O3, LLC — Department of Defense SBIR Phase I: AF211-CSO1

Clean O3, LLC — SBIR Phase I award from Department of Defense.

Phase I SBIR feasibility signal

  • Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from Department of Defense in a technical approach.
  • Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
  • Obligated amount $38,373. Cross-check similar awards in the same agency and technology tags for going-rate context.
  • Topic code AF211-CSO1 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.

Informational capture context from public federal data — not legal or bid advice.

Amount
$38,373
Agency
Department of Defense · Air Force
Program / Phase
SBIR · Phase I
Topic
AF211-CSO1
Solicitation
X21.1
NAICS
Place of performance
KS
Period
2021-04-16 → 2021-07-15

Description

The ability to efficiently and effectively sterilize non-line-of-sight locations within an aircraft has traditionally been a significant challenge for the DOD. Clean O3 solves these challenges with C.S.U (Compartment Sanitizing Unit), the next evolution of sterilization that provides personnel a self-contained, self-powered solution utilizing advanced ozone and atomization technology. Designed through independent testing, C.S.U assesses performance against sterilization benchmarks to identify systems level strengths and weaknesses in the elimination of the toughest pathogens. Directly aligned with Focus Area 14940, Clean O3 provides a solution that can sterilize non-line-of-sight locations within an aircraft with minimal support personnel or expertise. Sterilization can be achieved in an hour without the need for personnel to move equipment, seatbelts, or open compartments. This proprietary system, currently in development, will be self-sufficient by monitoring ozone and atomization in real time utilizing an internal monitoring sensor while the unit is in use.